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Abstract
Background: Non-celiac gluten sensitivity (NCGS) is still an undefined syndrome with several unsettled issues
despite the increasing awareness of its existence. We carried out a prospective survey on NCGS in Italian centers for
the diagnosis of gluten-related disorders, with the aim of defining the clinical picture of this new syndrome and to
establish roughly its prevalence compared with celiac disease.
Methods: From November 2012 to October 2013, 38 Italian centers (27 adult gastroenterology, 5 internal medicine,
4 pediatrics, and 2 allergy) participated in this prospective survey. A questionnaire was used in order to allow
uniform and accurate collection of clinical, biochemical, and instrumental data.
Results: In total, 486 patients with suspected NCGS were identified in this 1-year period. The female/male ratio
was 5.4 to 1, and the mean age was 38 years (range 3–81). The clinical picture was characterized by combined
gastrointestinal (abdominal pain, bloating, diarrhea and/or constipation, nausea, epigastric pain, gastroesophageal
reflux, aphthous stomatitis) and systemic manifestations (tiredness, headache, fibromyalgia-like joint/muscle pain,
leg or arm numbness, 'foggy mind,' dermatitis or skin rash, depression, anxiety, and anemia). In the large majority of
patients, the time lapse between gluten ingestion and the appearance of symptoms varied from a few hours to
1 day. The most frequent associated disorders were irritable bowel syndrome (47%), food intolerance (35%) and
IgE-mediated allergy (22%). An associated autoimmune disease was detected in 14% of cases. Regarding family
history, 18% of our patients had a relative with celiac disease, but no correlation was found between NCGS and
positivity for HLA-DQ2/-DQ8. IgG anti-gliadin antibodies were detected in 25% of the patients tested. Only a
proportion of patients underwent duodenal biopsy; for those that did, the biopsies showed normal intestinal
mucosa (69%) or mild increase in intraepithelial lymphocytes (31%). The ratio between suspected NCGS and new
CD diagnoses, assessed in 28 of the participating centers, was 1.15 to 1.
Conclusions: This prospective survey shows that NCGS has a strong correlation with female gender and adult age.
Based on our results, the prevalence of NCGS seems to be only slightly higher than that of celiac disease.
Please see related article http://www.biomedcentral.com/1741-7015/12/86.
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Background
In recent years, a growing number of subjects worldwide
have reported that ingestion of wheat and, to a lesser ex-
tent, of other cereals such as barley, rye, and spelt cause
them intestinal and extraintestinal symptoms without
the diagnostic features of celiac disease (CD) or wheat
allergy (WA) [1]. This self-reported wheat sensitivity has
fueled the debate on the possible existence of a new syn-
drome, which has been recently named as non-celiac
gluten sensitivity (NCGS) to differentiate it from CD
[2-4]. Gluten, the main protein complex contained not
only in wheat, but also in barley, rye, and spelt, has been
identified as the possible trigger of this syndrome. The
definition of NCGS has been questioned as possibly be-
ing too restrictive [5]. Indeed, it has been suggested that
wheat proteins other than gluten, such as amylase trypsin
inhibitors, can contribute to this disorder [6]. In addition,
recent studies have emphasized the possible role of fer-
mentable oligosaccharides, monosaccharides and disac-
charides and polyols (FODMAPs) in the development of
this syndrome [7]. Interestingly, together with milk, le-
gumes, honey, some fruits (watermelon, cherry, mango,
pear) and some vegetables (chicory, fennel, beetroot, and
leek), the most common food sources of FODMAPs also
include wheat and rye, the same grains and cereals that
also contain gluten proteins [8]. Despite awareness of
these limitations, for the time being the acronym NCGS
has been accepted by the scientific community, and it is
commonly used to indicate this syndrome, as reported in
the majority of published papers [2,3,9].
The prevalence of NCGS is far from being defined,
with only few available data, which are largely variable.
In the National Health and Nutrition Examination Sur-
vey, a primary care program designed to assess the health
and nutritional status of people in the USA, 49 cases of
suspected NCGS (0.6%) were identified in 7,762 subjects
in the period 2009 to 2010 [10], whereas at the University
of Maryland, a tertiary care center for the diagnosis of
gluten-related disorders, the criteria for NCGS were rec-
ognized in 347 (6%) of 5,896 patients observed between
2004 and 2010 [11].
The Italian Celiac Disease Association (AIC) together
with the Italian Coeliac Foundation (FC) promoted a
prospective multicenter survey on NCGS. The purpose
of this study was to provide a picture of patients with
suspected NCGS seen in Italian centers skilled in the
diagnosis of gluten-related disorders. An additional aim
was to define the ratio between suspected NCGS cases
and new CD diagnoses in order to get a rough idea of
their frequencies.
Methods
This prospective survey study was approved by the Ethical
Committee of S.Orsola-Malpighi Hospital in November
2012 (Authorization N° 243/2012/O/OssN). An informed
consent was obtained from each patient participating in
the study.
In total, 38 Italian centers (all recognized as referral
centers and included in the register of the Italian Health
Ministry for the diagnosis of gluten-related disorders)
participated in this study. Of these 38 centers, 27 were
centers of adult gastroenterology, 5 of internal medicine,
4 of pediatrics, and 2 of allergy. The survey started in
November 2012 and ended in October 2013, with a dur-
ation of 12 months. The design of the prospective survey
was planned by the members (UV, MTB, AC, RT, GRC)
of the AIC/FC scientific Board for NCGS, coordinated
by the authors UV (University of Bologna, Italy) and
GRC (University of Pavia, Italy). The study was carried
out by all the 38 investigators in charge of their own re-
ferral centers for the diagnosis of gluten-related disor-
ders. All patients seen in the outpatient clinics were
evaluated by skilled investigators, who identified sub-
jects with suspected NCGS. The diagnosis of NCGS was
made when the patient reported intestinal and extrain-
testinal symptoms occurring after the ingestion of glu-
ten, which improved or disappeared when gluten was
withdrawn from the diet, and recurred when gluten was
reintroduced into the diet. Because there are as yet no
biomarkers available, NCGS can be suspected only on
clinical grounds, after the exclusion of CD and WA,
based on negativity for anti-tissue transglutaminase
(anti-tTG) antibodies and anti-endomysial antibodies
(EmA) of the IgA class (for CD), and negativity for specific
IgE antibodies to wheat and/or skin prick tests (for WA).
The diagnostic criteria for NCGS have been extensively
quoted in the literature [11,12]. In order to facilitate ac-
curate collection of clinical, biochemical and instrumental
data, an NCGS questionnaire (Additional file 1) was de-
vised by the AIC/FC Board for NCGS. The questionnaire
included 60 items/questions to obtain a set of infor-
mation, including age and gender, gastrointestinal and
extraintestinal symptoms, symptom frequency, and time
interval between the ingestion of gluten and symptom
occurrence, who was the first to suspect NCGS (for ex-
ample, the patient, doctor, friend), associated disorders,
positivity for serum specific IgE or prick tests to food
and inhalants, family history of CD, serology for anti-
gliadin antibodies of first (AGA) and second genera-
tion (deamidated gliadin peptide; DGP) of the IgG and
IgA classes, biochemical abnormalities, human leukocyte
antigen (HLA) typing, and intestinal biopsy (when per-
formed). The questionnaire was filled in for each sus-
pected NCGS case by the main investigator of each
participating center. Once completed, the questionnaire
was entered in an online platform; data were processed by
BM (AIC Observatory) and evaluated by the two coordi-
nators (UV and GRC).
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In addition, 28 out of the 38 participating centers also
provided, together with the total number of suspected
NCGS cases, the total number of new CD diagnoses and
of patients seen in the period of the study, in order to
establish the ratio of NCGS diagnoses to total number
of patients seen, CD diagnoses to number of total pa-
tients seen and NCGS to CD. In total, 12,255 consecu-
tively observed patients were clinically evaluated by the
investigators, and underwent thorough diagnostic inves-
tigation, including blood tests and invasive procedures
(when needed) in order to confirm or exclude NCGS
and CD.
Results
During the 12 months of the prospective survey, the 38
participating centers (of which only 4 were pediatric
centers) identified 486 patients with suspected NCGS.
Of these, 410 were female (84%) with a female to male
ratio of 5.4 to 1. The mean age was 38 years (range 3 to
81 years). The large majority of patients reported more
than two associated gastrointestinal or extraintestinal
symptoms (Figure 1, Figure 2). Of the gastrointestinal
symptoms, the most frequent were bloating and abdom-
inal pain, found in 87% and in 83%, respectively, of the
patients with suspected NCGS. More than 50% of pa-
tients reported diarrhea, with the number of evacuations
per day ranging from 3 to 10, while 27% had alternating
bowel habits and 24% had constipation. After bloating
and abdominal pain, epigastric pain was the most fre-
quent symptom, being found in 52% of patients, fol-
lowed with decreasing prevalence by nausea, aerophagia,
gastroesophageal reflux disease, and aphthous stomatitis.
The most frequent extraintestinal manifestations were
tiredness and lack of well being, reported by 64% and
68%, respectively, of the enrolled subjects. In addition, a
high prevalence of neuropsychiatric symptoms including
headache (54%), anxiety (39%), 'foggy mind' (38%), and
arm/leg numbness (32%) were recorded. Other extrain-
testinal manifestations emerging from the analysis of
the survey responses were joint/muscle pain resembling
fibromyalgia (31%), weight loss (25%), anemia (due both
to iron deficiency and low folic acid; 22%), depression
(18%), dermatitis (18%) and skin rash (29%,). Less than
10% of patients showed a clinical picture of allergic
manifestations such as asthma or rhinitis.
In the study, 95% of patients with suspected NCGS
reported the appearance of the aforementioned symp-
toms every time or often after the ingestion of gluten-
containing food. In more than half of these patients,
the symptoms occurred within 6 hours after gluten in-
gestion; in about 40%, between 6 and 24 hours after in-
gestion; and in less than 10%, more than 24 hours after
ingestion. Symptoms appeared several months before
the diagnosis of NCGS was suspected in about 90% of
cases, whereas the existence of NCGS was hypothesized
within 1 month from its clinical onset in less than 2%
of cases.
The existence of NCGS was suspected by the patients
themselves or by gastroenterologists in more than 50%
of our cases, followed by the patient's general practi-
tioner (21%), homeopath/alternative medicine practi-
tioner (12%), friends (12%), or chemist (2%) (Figure 3).
The most frequent associated disorder in patients with
suspected NCGS was irritable bowel syndrome (IBS) (di-
agnosed according to Rome III criteria), detected in 47%
of cases. About 35% of patients had a previous diagnosis
of food intolerance, represented in most cases by lactose
intolerance. More than 20% of suspected patients with
NCGS patients had an allergy to one or more inhalants,
food, or metals, the most frequent being mites (26%), gra-
minaceae (24%), nickel (15%), cat/dog hair (13%), shellfish
(8%), and parietaria pollen (6%). About a half of patients
Figure 1 Gastrointestinal symptoms in suspected non-celiac
gluten sensitivity (NCGS). Prevalence (expressed as percentage) of
gastrointestinal manifestations in the 486 patients with suspected
NCGS identified in 38 Italian centers skilled in the diagnosis of
gluten-related disorders.
Figure 2 Extraintestinal manifestations in suspected non-celiac
gluten sensitivity (NCGS). Prevalence (expressed as percentage) of
extraintestinal manifestations in the 486 patients with suspected
NCGS identified in 38 Italian centers skilled in the diagnosis of
gluten-related disorders.
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with positive allergic tests had high levels of total serum
IgE. Eight graminaceae-positive patients showed a second-
ary IgE response to wheat, always at a very low titer and
without clinical manifestations of WA. One or more as-
sociated autoimmune diseases were present in 14% of
patients, mainly represented by autoimmune thyroiditis,
detected in two-thirds of the NCGS autoimmune sub-
group. Psoriasis and Graves’ disease were the other two
autoimmune disorders observed more frequently, whereas
myasthenia gravis, atrophic autoimmune gastritis, sclero-
derma, type 1 diabetes mellitus, Crohn’s disease and IgA
deficiency were sporadically present in these patients
(Figure 4). A clinical history of eating behavior and psychi-
atric disorders preceded the suspected diagnosis of NCGS
in 6% of cases.
Regarding family history, 18% of patients with sus-
pected NCGS had a first or second degree relative af-
fected by CD. No correlation was found with HLA-DQ2
and DQ8, found in 25% and 8% of patients, respectively.
As for the immune response to gliadin, AGA IgG were
the most frequent serological marker, being found in 76
(25%) of the 305 patients tested, whereas AGA IgA,
DGP IgG, and DGP IgA were positive in 6%, 6%, and 5%
of the cases studied, respectively (Figure 5).
Laboratory tests displayed low levels of ferritin, folic
acid, and vitamin D in 23%, 5%, and 11%, respectively, of
patients with suspected NCGS.
Duodenal biopsy was performed in 302 (62%) of the
486 patients, with the finding of Marsh 0 in 209 cases
(69%) and Marsh 1 in 93 cases (31%) according to the
modified Marsh-Oberhüber classification [13].
As specified in the Materials and Methods section, 28
centers (of which 4 were pediatric centers) reported the
total number of suspected NCGS cases, new CD diag-
noses, and patients observed during the period of the
study. Suspected NCGS and new CD diagnoses were re-
ported for 391 (3.19%) and 340 (2.77%), respectively of
the total of 12,255 patients, with a ratio of NCGS to CD
of 1.15 to 1. In the four pediatric centers, the number of
suspected NCGS cases compared with new CD cases
was far lower, with a ratio of NCGS to CD of 0.29 to 1.
When we excluded the pediatric centers, the ratio of
NCGS to CD was 1.25 to 1 in the remaining 24 centers
(Table 1).
Figure 3 Who was the first to suspect non-celiac gluten
sensitivity (NCGS)? Prevalence (expressed as percentage) of the
person who firstly suspected the existence of NCGS in the 486
patients hypothesized to suffer from this syndrome.
Figure 4 Disorders associated to suspected non-celiac gluten
sensitivity (NCGS). Prevalence (expressed as percentage ) of
associated disorders detected in the 486 patients with suspected
NCGS.
Figure 5 Immune response to gliadin in suspected non-celiac
gluten sensitivity (NCGS). Prevalence of anti-gliadin antibodies of
first (AGA) and second generation (deamidated gliadin peptide;
DGP) of the IgG and IgA classes in the 486 patients with suspected
NCGS.
Volta et al. BMC Medicine 2014, 12:85 Page 4 of 8
http://www.biomedcentral.com/1741-7015/12/85
Discussion
NCGS is still an undefined syndrome, with several unset-
tled issues despite the increasing awareness of its existence
[14]. One of the most critical aspects is the absence of bio-
markers, making it difficult to reach a clear-cut diagnosis.
Consequently, NCGS can be suspected only on the basis
of clinical response to gluten ingestion and withdrawal,
followed by gluten challenge after both CD and WA have
been excluded. The gold-standard assay for confirming
NCGS requires dietary elimination, followed by a double-
blind, randomized, placebo-controlled (DBPC) food chal-
lenge. This procedure is difficult to adopt routinely in
clinical practice, and to date, only a few DBPC studies
have been performed, showing that in a variable propor-
tion of patients classified as having NCGS, their symptoms
were caused by a nocebo effect [15-18]. Indeed, in a num-
ber of patients classified as being gluten-sensitive and put
on a gluten-free diet (GFD), the double-blind reintroduc-
tion of gluten did not result in recurrence of the symp-
toms, which were instead evoked by the ingestion of
placebo. The results of DBPC studies have been contro-
versial and, in some cases, even contradictory, with the
same authors who in a first study validated the existence
of this syndrome with the central role of gluten as trigger
concluding after more recent research that this syndrome
is unrelated to gluten and was improved by a low-
FODMAPs diet [16,18].
The above data emphasize how difficult it is to be sure
of NCGS diagnosis and, consequently, how its preva-
lence in the general population can only be defined
empirically. Indeed, studies in USA have reported a large
variability for NCGS prevalence with figures ranging
from 0.6% in primary care to 6% in tertiary care [10,11].
This high figure of NCGS is likely to be influenced by
the fact that many patients decide to avoid wheat and
gluten themselves without taking medical advice, because
they feel better if they do not eat gluten-containing foods.
In one recent study, a reassessment of patients who had
decided by themselves to avoid gluten allowed an alterna-
tive diagnosis to be made in about 30% of cases; these
diagnoses included small intestinal bacterial overgrowth,
fructose or lactose intolerance, microscopic colitis, gas-
troparesis, and pelvic floor dysfunction [19]. In a recent
paper from the UK, it was stated that the self-reported
prevalence for NCGS was 13% [20]. The mean age of indi-
viduals with self-reported gluten sensitivity was 39.5 years
(range 18 to 75 years), and 79% were females. About 5%
of children and adolescents in New Zealand were reported
to be avoiding gluten in their diet, without any evidence
for NCGS in many of these cases [21]. Therefore, it is
likely that the number of people worldwide following a
GFD is far higher than that of patients with true NCGS.
Previous papers on NCGS have shown that this syn-
drome is much more frequent in adulthood than in
childhood, and also in female than in male patients,
with a clinical picture characterized by a large combin-
ation of both gastrointestinal and extraintestinal symp-
toms [2,12,17,22].
To our knowledge, our study is the first multicenter
prospective survey on patients with suspected NCGS,
and it provides a picture of this syndrome in Italian cen-
ters for gluten-related disorder diagnosis. On one hand,
it must be emphasized that this study has major limita-
tions because the diagnosis of NCGS was highly pre-
sumptive in all our patients, being based exclusively on
clinical criteria and on exclusion of CD and WA. None
of our patients classified as having NCGS has had his/
her diagnosis confirmed by the gold-standard method
of testing (DBPC) and, as already reported, it is likely
that a proportion of patients identified as suspected
NCGS improved after GFD only because of the placebo
effect. However, the strengths of this study include the
large number of patients investigated and the high skill
level of the physicians working in the referral centers in-
volved in this survey. All the patients were prospectively
evaluated clinically by experts who planned the diagnostic
investigation based on blood tests and endoscopy to iden-
tify CD or NCGS.
Our study has a number of important findings. First,
our results confirm that suspected NCGS is much more
frequent in females than in males (5.4 to 1, respectively),
and that this syndrome can have its onset at any age, but
is much more common in adulthood, with the max-
imum peak in the fourth decade of life. Based on our
data, suspected NCGS was found in 3.19% of a clinical
group at risk for gluten-related disorders. Obviously, this
prevalence does not reflect that of suspected NCGS in
the general population, but, because the established pre-
valence of CD in the general population is 1%, and the
ratio between suspected NCGS and CD in our study was
1.15 to 1, we can extrapolate that the likely NCGS pre-
valence in the general population should be slightly higher
than 1%. In the four participating pediatric centers, the
prevalence of suspected NCGS was far lower than that of
Table 1 Ratio between suspected NCGS, new CD and
patients seen in 28 of the 38 Italian centers participating
in the study
All 28
centers
4 pediatric
centers
The other 24
centersa
NCGS/patients observed 391/12255 11/410 380/11845
3,19% 2,68% 3.21%
CD/patients observed 340/12255 38/410 302/11845
2,77% 9,26% 2,55%
NCGS/CD 391/340 11/38 380/302
1,15:1 0,29:1 1,25:1
CD, celiac disease; NCGS, non-celiac gluten sensitivity.
aInternal Medicine, Gastroenterology, Allergy.
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CD (0.29 to 1), confirming that this syndrome is rare in
childhood [22]. The clinical picture of NCGS emerging
from our study is a combination of IBS-like symptoms,
including abdominal pain, bloating, bowel habit abnor-
malities (either diarrhea or constipation), and systemic
manifestations such as tiredness, headache, fibromyalgia-
like joint/muscle pain, leg or arm numbness, 'foggy mind',
dermatitis or skin rash, depression, anxiety, aphthous sto-
matitis, and anemia (both iron and folate deficiency
anemia). From a clinical point of view it is relatively diffi-
cult to differentiate NCGS from CD because both condi-
tions share the same clinical features. In the large majority
of our patients with suspected NCGS, the time lapse be-
tween gluten ingestion and the occurrence of symptoms
varied from a few hours to 1 day, whereas in CD this
interval is much longer (up to weeks or years). In line with
the increased awareness of NCGS by specialists, it should
be emphasized that the diagnosis was suspected by a
gastroenterologist in a large number of cases. However, in
more than half of the cases, NCGS was a self-diagnosis
made by the patients, who started to avoid gluten in their
diet by themselves. In such cases, gluten reintroduction
for at least 6 weeks is highly recommended in order
to detect clear-cut histological changes consistent with
CD. Recently, it has been suggested that a 3-day gluten
challenge can disclose possible CD in patients with self-
prescribed GFD by evaluating HLA-DQ2-tetramer stain-
ing for gluten-specific T cells [23]. Because HLA typing
displays an almost absolute negative predictive value for
CD, the absence of HLA-DQ2 and DQ8 can exclude CD
in patients with suspected NCGS without the need of glu-
ten challenge [12].
As already emphasized by many papers [16,17,24],
NCGS is closely related to IBS, which was found in
about half of our NCGS subjects. In addition to IBS,
one-third of patients with suspected NCGS displays
another food intolerance (most frequently lactose
intolerance). A subgroup of patients with suspected
NCGS (around 20%) have an IgE-mediated allergy with
specific IgE to food and inhalants, the most frequent
allergens involved being mites, graminaceae, cat/dog
hair, and shellfish. Similar to patients with CD, a rela-
tively high number of patients with suspected NCGS de-
velops nickel allergy. Published studies have previously
reported that patients with suspected NCGS did not
seem to present major autoimmune comorbidities
[11,12]. Unlike these reports, our present study high-
lights that there is a high prevalence of Hashimoto thy-
roiditis in patients with suspected NCGS and that other
autoimmune conditions such as psoriasis and Graves’
disease seem to be relatively common in these patients.
In this respect, NCGS might behave in a similar way to
CD, which is characterized by a close association with a
wide spectrum of autoimmune disorders.
As already demonstrated [12], NCGS was commonly
detected in first-degree relatives of celiacs. However, the
genetic typing excluded any relationship between NCGS
and HLA-DQ2 and/or HLA-DQ8, which were found in
patients with suspected NCGS at a prevalence very close
to that of the general population. Interestingly, labora-
tory findings indicated that more than 20% of patients
with suspected NCGS showed biochemical signs of mal-
absorption, with low levels of ferritin or folic acid or
vitamin D. These biochemical deficiencies, which were
less pronounced than in CD, might be due to small bo-
wel inflammation reported in NCGS [2,14]. In line with
this hypothesis, an increased number of intraepithelial
lymphocytes, consistent with a type 1 lesion according
to Marsh-Oberhuber classification, has been documen-
ted in the intestinal biopsy of about 30% of patients with
suspected NCGS. In the majority of the suspected NCGS
subgroup identified at Bologna center (by UV), a typical
linear distribution of CD3+ T lymphocytes in the deeper
part of mucosa and clusters of CD3+ T lymphocytes in
the superficial epithelium were observed, in accordance
with the pattern identified as a possible histological mar-
ker of NCGS [25].
Although no biomarker has been identified to date,
previous studies have reported that about 50% of pa-
tients with suspected NCGS show positivity for AGA,
mainly of the IgG class [11,12,17]. These antibodies are
not specific for NCGS, being also found in CD, auto-
immune liver disorders, connective tissue disease and IBS,
as well as in healthy controls [26], but their finding in pa-
tients with a clinical picture consistent with NCGS has
been regarded as an element supporting this diagnosis
[27]. In this study, AGA IgG were confirmed as the most
frequent serological marker found in patients with sus-
pected NCGS, but AGA prevalence was lower than that
reported in previous papers (25% vs 50%) [11,12,17]. The
lower AGA finding in our study can be explained by the
fact that many of our patients had diagnosed themselves
with a gluten disorder, thus they were already on a GFD
when tested, and AGA tend to disappear very quickly in
patients with NCGS after GFD [28]. Positivity for AGA
IgA, DGP IgG and DGP IgA were found in only a few
patients (5% to 6%).
Conclusions
The present study provides a picture of suspected NCGS,
but we must emphasize the major limitation of the study,
namely that the diagnosis of NCGS remained highly
presumptive in all our patients, because it was not es-
tablished by a confirmatory DBPC. A proportion of
patients classified as suspected NCGS might improve
after GFD only because of the placebo effect. However,
even with its limitations, this prospective survey
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indicates that NCGS may be a frequent finding
among patients referred to centers for the diagnosis of
gluten-related disorders. This study confirms that this
new gluten-induced syndrome appears to have a strong
correlation with female gender and adult age, and has a
prevalence that might be slightly higher than that of CD,
but is certainly far lower than that hypothesized on the
basis of previous reports.
Additional file
Additional file 1: Questionnaire for non-celiac gluten sensitivity
(NCGS) prospective survey promoted by the Italian Association for
Celiac Disease (AIC) and Celiac Foundation (FC).
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